期刊文献+

SOX-9转染骨髓基质细胞与聚乳酸-羟基乙酸共聚物的生物相容性 被引量:1

Biocompatibility of SOX-9 transfected bone marrow stroma cells with poly lactic-co-glycolic acid complex
下载PDF
导出
摘要 背景:Sox基因家族是一个新发现的基因家族,在胚胎发育、性别分化、神经系统及骨骼系统发育过程中起着重要的作用。目的:观察SOX-9基因转染骨髓基质干细胞后在聚乳酸-羟基乙酸共聚物培养生长的生物相容性,以及其复合材料修复软骨缺损动物模型的可行性。方法:将SOX-9基因转染成功后的骨髓基质细胞在聚乳酸-羟基乙酸共聚物培养生长,制备软骨缺损动物模型,将复合物植入软骨缺损,通过大体标本观察、组织学观察及Ⅱ型胶原免疫组织化学及RT-PCR检测对软骨缺损模型的修复效果。结果与结论:SOX-9基因转染骨髓基质干细胞后可以在聚乳酸-羟基乙酸共聚物上正常生长,并有Ⅱ型胶原的高表达,将复合物植入软骨缺损后,可以修复软骨缺损动物模型。聚乳酸-羟基乙酸共聚物与转染后的骨髓基质细胞具有良好的生物相容性,可以修复兔软骨缺损动物模型。 BACKGROUND:Sox gene family is a newly discovered gene family,it plays an important role in the process of embryonic development,sex differentiation,development of nervous system and skeletal system.OBJECTIVE:To investigate the biocompatibility of SOX-9 gene transfected bone marrow stroma cells (BMSCs) with poly lactic-co-glycolic acid (PLGA) complex,and the feasibility of BMSCs transfected by SOX-9 gene for repairing cartilage defect in animal models.METHODS:BMSCs successfully transfected by SOX-9 gene were cultured on PLGA copolymer,and animal models with cartilage defect were prepared.The complex was planted into defect site of animal model.The effect of repair was evaluated by macroscopic sample observation,histological observation,collagen Ⅱ immunohistochemistry and RT-PCR.RESULTS AND CONCLUSION:BMSCs transfected by SOX-9 gene grew on PLGA copolymer well and high expression of collagen Ⅱ was observed.The complex transplanted into defect site could repair the cartilage defects in animal model.There is well biocompatibility between PLGA copolymer the transfected BMSCs.The complex could repair the cartilage defect in rabbit models.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2010年第51期9559-9562,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 深圳市科技计划资助项目(JH200505260325A)~~
  • 相关文献

参考文献2

二级参考文献14

  • 1Breitbart AS, Grande DA, Mason JM, et al. Gene-enhanced tissue engineering : applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene.Ann Plast Surg, 1999, 42(5) : 488.
  • 2Oakes D, Lieberman J. Osteoinductive applications of regionsl gene therapy: ex vlvo gene transfer. Clin Orthop, 2000, 379(Suppl) : 101.
  • 3Anderson W. Gene therapy. The best of times, the worst of times. Science, 2000, 288(5466) : 627.
  • 4Guo XD, Zheng QX, Du JY, et al. Molecular Tissue Engineering: Concepts, Status and Challenges. J Wuhan Univer Technol,Mater Sci Ed, 2002,17(3) : 30-34.
  • 5Ferber D. Tissue engineering: lab-grown organs begin to take shape. Science, 1999, 284(5413) : 422.
  • 6Boyan B, Lohmann C, Romero J, et al. Bone and cartilage tissue engineering. Clin Plast Surg, 1999, 26(4): 629.
  • 7Reddi A. Morphogenesis and tissue engineering of bone and cartilage : inductive signals, stem cells, and biomimetlc biomaterials. Tissue Eng, 2000, 6(4) : 351.
  • 8Pittenger M, Mackay A, Beck S, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284(5411): 143.
  • 9Radomsky M, Thompson A,Spiro R, et al . Potential role of fibroblast growth factor in enhancement of fracture healing.Clin Orthop,1998, 355(Suppl) : 283.
  • 10Caplan AI. Mesenchymal stem cells and gene therapy. Clin Orthop, 2000,379(Suppl) : 67.

共引文献19

同被引文献26

  • 1Strauss EJ ,Goodrich LR,Chen CT,et al. Biochemical andbiomechanical properties of lesion and adjacent articularcartilage after chondral defect repair in an equine model[J]. Amer J Sp Med,2005 ,33(11) : 1647-1653.
  • 2Wright E, Hargrave MR,Christiansen J, et al. Gangadha-ran U,greenfield a,koopman P. The Sry-related geneSox9 is expressed during chondrogenevsis in mouse embry-os[J]. Nat Genet,1995,9(1) :15-20.
  • 3Lefebvre V,Huang WD, Harley VR,et al. SOX9 is a po-tent activator of the chondrocyte-specific enhancer of thepro alpha 1(H) collagen gene[J]. Mol Cell Biol, 1997,17(4):2336-2346.
  • 4Lefebvre V,Behringer RR,De Crombrugghe B, L-Sox5,Sox6 and Sox9 control essential steps of the chondrocytedifferentiation pathway [J], Osteoarthritis and Cartilage,2001,9CA) :S69-S75.
  • 5Akiyama H. Control of chondrogenesis by the transcrip-tion factor Sox9 [J], Mod Rheumatol,2008,18 (3) - 213-219.
  • 6Kim JH,Park JS,Yang HN,et al. The use of biodegrada-ble PLGA nanoparticles to mediate SOX9 gene delivery inhuman mesenchymal stem cells (hMSCs) and inducechondrogenesis[J]. Biomaterials,2011,32(1) :268-278.
  • 7Stock M,Otto F. Control of RUNX2 isoform expression:the role of promoters and enhancers[J], J Cell Biochem,2005,95(3):506-517.
  • 8Drissi H,Luc Q, Shakoori R, et al. Transcriptional auto-regulation of the bone related CBFA1/RUNX2 gene[J]. JCell Physiol,2000,184(3) :341-350.
  • 9Enomoto H, Furulchl T, Zanma A,et al. RUNX-2 cleftciencyin chondrocytes causes adipogenic changes in vitro [J]. CellSci,2004,117(Pt 3)..417-425.
  • 10Kobayashi H?Gao Yh? Ueta C, et al. Multilineage differ-entiation of Cbfal-deficient calvarial cells in vitro[J]. Bio-chem Biophys Res Commun,2000,273(2) :630-636.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部